→ Juno Therapeutics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Juno Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2018-03-05	SC	CELGENE CORP /DE/	—	—	view →
2018-02-14	SC	CELGENE CORP /DE/	—	—	view →
2018-02-07	SC	BRATTON DOUGLAS K	—	—	view →
2018-02-02	SC	CELGENE CORP /DE/	—	—	view →

Other Filings by CELGENE CORP /DE/

Filed	Form	Issuer	Stake	Shares
2019-01-22	SC	ACCELERON PHARMA INC	—	—	view →
2018-03-05	SC	Juno Therapeutics, Inc.	—	—	view →
2018-02-14	SC	Juno Therapeutics, Inc.	—	—	view →
2018-02-08	SC	CRISPR Therapeutics AG CRSP	—	—	view →
2018-02-02	SC	Juno Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →